Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part II: Long-Term Outcome and Postmortem Analysis of Bilateral Pallidotomy in the Pre-Levodopa Era.

Hamel W, Köppen JA, Müller D, Hariz M, Moll CKE, Krack P.

Stereotact Funct Neurosurg. 2018;96(6):353-363. doi: 10.1159/000495412. Epub 2019 Jan 16. Review.

2.

Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.

Hidding U, Gulberti A, Pflug C, Choe C, Horn A, Prilop L, Braaß H, Fründt O, Buhmann C, Weiss D, Westphal M, Engel AK, Gerloff C, Köppen JA, Hamel W, Moll CKE, Pötter-Nerger M.

Parkinsonism Relat Disord. 2019 May;62:141-147. doi: 10.1016/j.parkreldis.2018.12.026. Epub 2018 Dec 28.

PMID:
30616868
3.

Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease Patients.

Holt AB, Kormann E, Gulberti A, Pötter-Nerger M, McNamara CG, Cagnan H, Baaske MK, Little S, Köppen JA, Buhmann C, Westphal M, Gerloff C, Engel AK, Brown P, Hamel W, Moll CKE, Sharott A.

J Neurosci. 2019 Feb 6;39(6):1119-1134. doi: 10.1523/JNEUROSCI.1913-18.2018. Epub 2018 Dec 14.

4.

Towards unambiguous reporting of complications related to deep brain stimulation surgery: A retrospective single-center analysis and systematic review of the literature.

Engel K, Huckhagel T, Gulberti A, Pötter-Nerger M, Vettorazzi E, Hidding U, Choe CU, Zittel S, Braaß H, Ludewig P, Schaper M, Krajewski K, Oehlwein C, Mittmann K, Engel AK, Gerloff C, Westphal M, Moll CKE, Buhmann C, Köppen JA, Hamel W.

PLoS One. 2018 Aug 2;13(8):e0198529. doi: 10.1371/journal.pone.0198529. eCollection 2018.

5.

Spatio-temporal dynamics of cortical drive to human subthalamic nucleus neurons in Parkinson's disease.

Sharott A, Gulberti A, Hamel W, Köppen JA, Münchau A, Buhmann C, Pötter-Nerger M, Westphal M, Gerloff C, Moll CKE, Engel AK.

Neurobiol Dis. 2018 Apr;112:49-62. doi: 10.1016/j.nbd.2018.01.001. Epub 2018 Jan 4.

6.

Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences.

Buhmann C, Huckhagel T, Engel K, Gulberti A, Hidding U, Poetter-Nerger M, Goerendt I, Ludewig P, Braass H, Choe CU, Krajewski K, Oehlwein C, Mittmann K, Engel AK, Gerloff C, Westphal M, Köppen JA, Moll CKE, Hamel W.

PLoS One. 2017 Jul 5;12(7):e0178984. doi: 10.1371/journal.pone.0178984. eCollection 2017.

7.

Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists.

Hamel W, Köppen JA, Alesch F, Antonini A, Barcia JA, Bergman H, Chabardes S, Contarino MF, Cornu P, Demmel W, Deuschl G, Fasano A, Kühn AA, Limousin P, McIntyre CC, Mehdorn HM, Pilleri M, Pollak P, Rodríguez-Oroz MC, Rumià J, Samuel M, Timmermann L, Valldeoriola F, Vesper J, Visser-Vandewalle V, Volkmann J, Lozano AM.

World Neurosurg. 2017 Mar;99:41-46. doi: 10.1016/j.wneu.2016.11.012. Epub 2016 Nov 9.

PMID:
27838430
8.

The Pioneering and Unknown Stereotactic Approach of Roeder and Orthner from Göttingen. Part I. Surgical Technique for Tailoring Individualized Stereotactic Lesions.

Hamel W, Köppen JA, Hariz M, Krack P, Moll CK.

Stereotact Funct Neurosurg. 2016;94(4):240-253. Epub 2016 Sep 16. Review.

9.

Activity parameters of subthalamic nucleus neurons selectively predict motor symptom severity in Parkinson's disease.

Sharott A, Gulberti A, Zittel S, Tudor Jones AA, Fickel U, Münchau A, Köppen JA, Gerloff C, Westphal M, Buhmann C, Hamel W, Engel AK, Moll CK.

J Neurosci. 2014 Apr 30;34(18):6273-85. doi: 10.1523/JNEUROSCI.1803-13.2014.

10.

The influence of tamoxifen on the secretion of transforming growth factor-beta2 (TGF-beta2) in glioblastomas: in vitro and in vivo findings.

Puchner MJ, Köppen JA, Zapf S, Knabbe C, Westphal M.

Anticancer Res. 2002 Jan-Feb;22(1A):45-51.

PMID:
12017331
11.

Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.

Grimm EA, Bruner JM, Carinhas J, Köppen JA, Loudon WG, Owen-Schaub L, Steck PA, Moser RP.

Cancer Immunol Immunother. 1991;32(6):391-9.

PMID:
1848799
12.

Lymphokine (IL-2 and TNF-alpha) mediated cytolytic activity against glioma cells in vitro.

Herrmann HD, Köppen JA, Kühl N, Raschdorf C, Westphal M.

Cancer Treat Rev. 1989 Jun;16 Suppl A:21-7. No abstract available.

PMID:
2788505
13.

Initiation of primary cell cultures from human intracranial tumors on extracellular matrix from bovine corneal endothelial cells.

Westphal M, Hänsel M, Brunken M, König A, Köppen JA, Herrmann HD.

Exp Cell Biol. 1987;55(3):152-63.

PMID:
2444474

Supplemental Content

Loading ...
Support Center